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Introduction 
The purpose of this article is to examine the potential associations between the 2657 single 
nucleotide polymorphisms (SNPs) and 16 possible risk factors for temporomandibular disorders 
(TMD) selected from two genetic association studies: Orofacial Pain Prospective Evaluation and 
Risk Assessment (OPPERA) study and COMT study. 
OPPERA Study: 
The Orofacial Pain Prospective Evaluation and Risk Assessment (OPPERA) study is a large 
prospective case control study. One of the purposes of OPPERA was to examine the influences 
of genetic factors on the onset and persistence of temporomandibular disorders (TMD)1.  
The OPPERA baseline case control study used advertisement methods to recruit people who 
had chronic TMD and people who did not in 2006-2008 from four academic health centers in 
Baltimore MD, Buffalo NY, Chapel Hill NC, and Gainesville FL. After selection based on several 
criteria, the final number of participants OPPERA included are 166 cases and 1442 controls. 
Also, 3295 single nucleotide polymorphisms assessed, representing 358 genes2. 
COMT Study: 
In order to increase the power of the OPPERA study, additional subjects from the COMT cohort, 
which was conducted by UNC, were added to the OPPERA datasets. The 182 cases in the COMT 
cohort were recruited through the UNC Orofacial Pain Clinic, and 170 controls were recruited 
by community wide advertisement. Both cases and controls in the COMT cohort were non-
Hispanic white females2.  
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These two genetic association studies of TMD collected a large set of intermediate phenotypes, 
including clinical, psychosocial, autonomic and sensory variables. The four criteria for 
intermediate phenotypes are: associated with TMD in the population; heritable; manifests in an 
individual independent of active disease; cosegregates with TMD in families3. The 16 risk factors 
that are investigated in this research satisfied the criteria of intermediate phenotypes, and are 
listed below. 
The clinical intermediate phenotypes4 include count of non-specific orofacial symptoms and 
count of comorbid conditions. 
The psychosocial intermediate phenotypes5 include the Pennebaker Inventory of Limbic 
Languidness, the depression, anxiety and somatization subscales of the SCL 90R, the perceived 
stress scale, state-trait anxiety inventory, physical health composite score of Rumination, and 
the rumination, magnification and helplessness subscales of the pain catastrophizing scale. 
The pain sensitivity intermediate phenotypes6 include pressure main threshold (measured at 
trapezius), thermal tolerance, heat pain sensitivity measured at 50 degrees Celsius, and the sum 
of 10 heat pain measures at 50 degrees Celsius. 
After combining the datasets of the OPPERA and COMT studies, the analysis dataset consists of 
2657 SNPs and the 16 risk factors (intermediate phenotypes). Since the data was collected 
during two case control studies, the data is not a random sample from the population, so our 
estimates of the effect of SNPs on the intermediate phenotypes could be biased. The sample 
can be seen as a stratified sample with two strata: cases and controls of TMD. Inverse 
probability of sampling weighted regression model (IPW)7 was used to address the potential 
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bias in this stratified sample. The output table for regression analysis consists of the p values, t 
values, confidence intervals and estimates for each SNP and each secondary trait variable. 
QQ plots was used to investigate the significance p values that may be of interest. The results 
show that three observations lie between false discovery rate (FDR) =0.2 and FDR=0.1 line for 
heat pain sensitivity, which can be interpreted as significant. Also, one observation lies between 
FDR=0.05 and FDR=0.1 line in the QQ plot of heat pain windup. However, the plot shows an 
obvious inflation so more investigation should be performed before reaching conclusions. 
Our next steps include investigations of the three SNPs whose p values are extremely low for 
heat pain sensitivity to find out if they have signification associations, given the inflation and 
correlation between SNP’s. Also, we will check the causes the inflation in the QQ plot of heat 
pain windup.  
 
Analysis method 
Data Management 
16 intermediate phenotypes were selected from both the OPPERA and the COMT datasets, with 
TMD status (0=control, 1=case). The specific construct and meaning of these intermediate 
phenotypes are listed below: 
Trapezius algometer6: the variable was defined by the pain pressure thresholds of the center of 
trapezius assessed using a commercially available pressure algometer. The examiner would 
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increase the pressure at a steady rate of 30 kPa/s, until the participant indicated first pain 
sensation by pressing a button. 
Heat pain sensitivity and Heat pain windup6: the variables defined by the heat pain thresholds 
of the forearms assessed using a commercially available thermal stimulator. The examiner 
placed the ATS thermode in contact with the skin at 32 °C, and then would increase the 
temperature at a rate of 0.5 °C/second, until the participant indicated the first pain sensation 
by pressing a button. Heat pain sensitivity was evaluated using the first pain rating in the series 
of 10, and heat pain temporal summation was evaluated by taking the sum of the 10 pain 
ratings. 
Thermal tolerance6: the variable was defined by the heat pain tolerance of the forearms 
assessed using the same thermal stimulator following the similar protocol as the measure of 
heat pain sensitivity. The participant would press the button to indicate s/he could no longer 
tolerate the pain. For both heat pain thresholds and heat pain tolerance, the ceiling 
temperature was set at 52 °C and was recorded when participant fail to press the button in 
each trial. 
Pennebaker Inventory of Limbic Languidness (PILL)5: The PILL assesses the frequency with which 
individuals are bothered by each of 54 common physical symptoms and sensations on a five-
category scale.  
Measures of psychological distress (depression, anxiety, somatization)5: these three variables 
are among the 90 psychological symptoms evaluated by the Symptom Checklist 90-Rivised (SCL-
90R). Participants report the extent to which they have been bothered by each symptom.  
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The Perceived Stress Scale (PSS)5: The variable assesses the perception of stress. For each of the 
10 items, participants described how often in the past five months they felt stressful. The 
perceived stress core was evaluated by summing the numerical weight of each item. 
State-trait anxiety inventory (Y1 and Y2)5: The state-trait anxiety inventory consists of two 20-
items questionnaires: state anxiety inventory and trait anxiety inventory. State anxiety 
inventory asks participants to describe their feelings (for the 20 items) at their current state, 
while trait anxiety inventory asks participants to describe their general feelings. 
The Pain Catastrophizing Scale (Rumination, Magnification, and Helplessness)5: Rumination, 
magnification and helplessness are three subscales of the pain catastrophizing scale. 
Participants indicate the degree to which they have specified thoughts and feelings when 
experiencing pain, and the scores were calculated for each subscale. 
Count of comorbid conditions4: the count of comorbid conditions was one of the measure of 
health status, which was assessed by a checklist inquiring into past or current conditions. The 
comorbities include overlapping pain condition or other functional disorders. 
Count of non-specific orofacial symptoms4: the count of non-specific orofacial symptoms was 
one of the measures of clinical status. Six jaw symptoms (such as ache or fatigue) were 
evaluated, the total count of symptoms was used a summary score. 
After selecting these 16 intermediate phenotypes, the two datasets were then merged by ID, 
generating the intermediate phenotypes dataset. The intermediate phenotypes dataset was 
then merged with the genetics analytical dataset (which was generated by combining the SNPs 
from the two cohorts) by ID. After removing participants that only exist in one of the datasets, 
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the final analytical dataset for this study consists of 1946 participants, with their TMD status, 
covariates (C1, C2, site1, site2, site2, site4, sex), 16 interested variables and 2657 SNPs. 
A spreadsheet of allele frequencies was generated, and SNP’s with a minor allele frequency 
(MAF) of less than 0.02 were included to increase the power of the study. 
Inverse-probability-of-sampling-weighted (IPW) regression7 
The explicit goal of OPPERA project and COMT study is to analyze the association between 
genotypes and TMD case status, which adopted a case control design that implicitly conditions 
on a primary disease (TMD) outcome. The data from thesis two studies investigates the 
associations between the intermediate phenotypes and SNPs based on stratified sample (two 
strata, one for cases and one for controls). The prevalence of cases in the sample is much 
greater than that in the general population. Common analysis approaches which ignore the 
ascertainment or adjust the ascertainment by TMD status will lead to inflated type I error rate 
for tests of association between genotypes and intermediate phenotypes, and also provide 
biased estimates of the effects of marker genotypes on the intermediate phenotypes. 
The purpose of this study is to analyze the associations between marker genotypes and 
intermediate phenotypes (the 16 intermediate phenotypes as we described above). These 
associations can be viewed as an analysis of case control data with biased sampling. One 
possible approach to deal with this situation is the inverse probability of sampling weighted 
regression model7.The IPW regression model is a linear model with two different weights to the 
two strata (cases and controls of TMD in this case). The weights come from the reciprocal of the 
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selection probability of TMD status, which is given by the number of observations in each 
condition times the prevalence of the condition: 
ܥܽݏ݁: ݓଵ = ݌ଵ ∗
ଵ
௡భ
= ଴.଴ହ
௡భ
  
ܥ݋݊ݐݎ݋݈: ݓ଴ = ݌଴ ∗
ଵ
௡బ
= ଴.ଽହ
௡బ
  
Where ݌ଵ represents the prevalence of cases in general population, ݌଴ represents the 
prevalence of controls in general population, ݊ଵ represents the number of cases in the sample 
and ݊଴ represents the number of controls in the sample. 
Equivalently, we set the weight of TMD-free controls to 1. Then the weight of TMD cases is: 
଴.଴ହ
଴.ଽହ
∗ ௡భ
௡బ
.  
QQ plot for p values 
Since we use IPW regression for each SNP and each secondary traits, the output table of results, 
which contains the estimates, confidence intervals, t values, p values for 2657 SNPs, is hard to 
interpret with the naked eye. Quantile-Quantile (QQ) plots of the p values were used to 
investigate if any special p value (extremely low) exists. The Quantile distribution of the 
observed -log p values are plotted on the y axis versus the quantile distribution of the expected 
-log p values, which are plotted on the x axis. The expected -log p values were determined by 
creating a vector of N values (N is the number of p values) evenly spaced from 1 to 1 / N, taking 
the -log of each of these values and ranking them from smallest to largest. If there are no 
associations between SNPs and intermediate phenotype, the p values will form a straight line 
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on the QQ plots because the observed distribution of p values will follow a uniform distribution. 
If there are such associations, which will generate extremely low p values, those p values would 
not follow the uniform distribution, and thus diverge from the straight line.  
The false discovery rate (FDR) of a series of tests is the proportion of “significant” tests that are 
false positives. Three lines corresponding: FDR=0.2, FDR=0.1, FDR=0.05 are shown for in the QQ 
plot. If the observations on QQ plots lie above FDR=0.05 line, it means that if all tests 
corresponding to points above the line are treated as “significant”, then no more than 5% of 
these tests should be false positives. We can perform further investigations those p values that 
fall outside of the expected pattern. Observations that lie above 0.1 or 0.2 are more likely to be 
false positives, but we can still investigate these SNP’s in future studies. 
Adjusting for covariates 
The allele frequencies differences between cases and controls in genetic association study 
caused by population stratification can cause spurious associations in regression analysis. The 
following figure shows the QQ plots of the p values produced by performing an unadjusted 
regression analysis to evaluate the association between the SNP’s and the phenotype. We can 
see inflation in all of the plots, resulting in spurious associations between the SNPs and the 
intermediate phenotypes. 
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The race eigenvectors produced by EIGENSTRAT8, adjust for population stratification since SNPs 
whose allele frequencies are different in different races be associated with C1 and C2. Also, as 
noted earlier, the regression analysis included covariates for sex and OPPERA study site. 
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Result  
The 16 QQ plots were generated after adjusting for the covariates: 
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All plots except the plot of heat pain sensitivity and heat pain windup follow a straight line 
below FDR=0.2, which means that no significant associations were observed between the SNPs 
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and the intermediate phenotypes. However, there were two QQ-plots that showed evidence of 
an association, namely the QQ plots for heat pain sensitivity and heat pain windup.  
From the plots of heat pain sensitivity, 3 SNPs lie between the FDR=0.2 and FDR=0.1 lines, 
which suggests that 20% of these three SNP’s are false positives. Also, 1 observation lies 
between the FDR=0.1 and FDR=0.05 lines in the plot of heat pain windup, which suggests that 
there is a 10% change that this association is a false positive. Although these observations 
above three FDR lines may suggest relatively low p values, further investigation must be 
performed to confirm our conjecture that these associations are significant.  
 
 
 
Discussion 
Heat pain sensitivity contains three observations that lie above the FDR=0.2 line, which suggest 
that 20% of thesis SNP’s are false positives. However, concluding that these three observations 
are significant associations just based on the QQ plot is premature. Our next step will be to 
investigate which three SNPs these three observations represent. We will run the regression 
analysis for these three SNPs again to obtain their p values. Also, observations that lie near 
each other in a QQ plot for p values may be the result of some correlations between SNPs (like 
they are in the same chromosome, etc.). We can further investigate the SNP map to investigate 
the correlation between these SNPs. Based on the p values and our further investigation of SNP 
correlation, we seek to obtain a more information about the associations between these SNPs 
and heat pain sensitivity. 
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For the QQ plot for heat pain windup, although one observation passes the FDR=0.1 line, we 
can see clear evidence of inflation in the plot. Our next step is to investigate the causes of the 
inflation and add additional covariates (such as higher-order eigenvectors) to the regression 
models to attempt to reduce this inflation. 
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